drugset / Trial / NCT00677391

Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population

NCT00677391

Phase 3 Completed 103 enrolled Abbott
RandomizedParallel-groupTriple-blindTreatment

Summary

The primary objective of this study was to evaluate the efficacy and the safety of sibutramine vs. placebo in combination with a hypocaloric diet on weight-loss in overweight and obese Malaysian subjects.

Timeline

Start
2002-12
Primary completion
2004-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sibutramine Small molecule 10 mg
Comparator Sibutramine Small molecule 15 mg

Indications